Literature DB >> 428696

Characterisation of somatostatin release from the pancreas: the role of calcium and acetylcholine.

K Hermansen, S E Christensen, H Orskov.   

Abstract

The effect of calcium on somatostatin secretion was investigated in the isolated, perfused canine pancreas preparation and compared with those of acetylcholine, glucose, isoproterenol and arginine. Calcium (5 mmol/l) stimulated somatostatin release in a typical biphasic response pattern being about 5 times as potent as acetylcholine (1 mumol/l), arginine (5 mmol/l), and isoproterenol (2 ng/ml) while the release of insulin and glucagon in response to calcium and the other secretagogues were of the same magnitude. Somatostatin release increased progressively when perfusate calcium was increased step-wise from 0 through 1.25 and 2.5 to 5.0 mmol/l. Calcium stimulated the secretion of somatostatin in the absence of glucose. The stimulatory effect of calcium was, however, modulated by the glucose concentration being about twice as large at 200 mg/100 ml as at 25 mg/100 ml glucose in the perfusion medium.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 428696     DOI: 10.1007/bf01221953

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

1.  Radioimmunoassay for GH-release inhibiting hormone.

Authors:  A Arimura; H Sato; D H Coy; A V Schally
Journal:  Proc Soc Exp Biol Med       Date:  1975-03

2.  Calcium, glucose and glucagon release.

Authors:  J Iversen; K Hermansen
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

3.  Inhibition of pancreatic glucagon release by somatostatin: in vitro.

Authors:  J Iversen
Journal:  Scand J Clin Lab Invest       Date:  1974-04       Impact factor: 1.713

4.  Synthesis of 125I monolabelled 3, 5, 3'-triiodothyronine and thyroxine of maximum specific activity for radioimmunoassay.

Authors:  J Weeke; H Orskov
Journal:  Scand J Clin Lab Invest       Date:  1973-12       Impact factor: 1.713

5.  Inhibition of insulin secretion by somatostatin.

Authors:  K G Alberti; N J Christensen; S E Christensen; A P Hansen; J Iversen; K Lundbaek; K Seyer-Hansen; H Orskov
Journal:  Lancet       Date:  1973-12-08       Impact factor: 79.321

6.  Measurement of and correction for incubation damage in radioimmunoassay.

Authors:  H Orskov; K Seyer-Hansen
Journal:  Eur J Clin Invest       Date:  1974-06       Impact factor: 4.686

7.  Modulation of pancreatic somatostatin by adrenergic and cholinergic agonism and by hyper- and hypoglycemic sulfonamides.

Authors:  E Samols; G C Weir; R Ramseur; J A Day; Y C Patel
Journal:  Metabolism       Date:  1978-09       Impact factor: 8.694

8.  Measurements of somatostatin-like immunoreactivity in plasma.

Authors:  V Harris; J M Conlon; C B Srikant; K McCorkle; V Schusdziarra; E Ipp; R H Unger
Journal:  Clin Chim Acta       Date:  1978-07-15       Impact factor: 3.786

9.  Effect of Verapamil on pancreatic glucagon release from the isolated, perfused canine pancreas.

Authors:  K Hermansen; J Iversen
Journal:  Scand J Clin Lab Invest       Date:  1977-04       Impact factor: 1.713

10.  Cation requirements for insulin secretion in the isolated perfused pancreas.

Authors:  G M Grodsky; L L Bennett
Journal:  Diabetes       Date:  1966-12       Impact factor: 9.461

View more
  13 in total

Review 1.  Neural regulation of the endocrine pancreas.

Authors:  F C Brunicardi; D M Shavelle; D K Andersen
Journal:  Int J Pancreatol       Date:  1995-12

2.  Autonomic function and control of pancreatic somatostatin.

Authors:  E Samols; J I Stagner; G C Weir
Journal:  Diabetologia       Date:  1981-03       Impact factor: 10.122

3.  Possible involvement of the cholinergic system in hormonal secretion by the perfused pancreas from ventromedial-hypothalamic lesioned rats.

Authors:  F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Diabetologia       Date:  1981-03       Impact factor: 10.122

Review 4.  Secretion of somatostatin from the normal and diabetic pancreas. Studies in vitro.

Authors:  K Hermansen
Journal:  Diabetologia       Date:  1980       Impact factor: 10.122

5.  Stimulation of somatostatin secretion by 3-O-methylglucose in the perfused dog pancreas.

Authors:  K Hermansen; S Lindskog; B Ahrén
Journal:  Int J Pancreatol       Date:  1996-10

6.  Splanchnic neural regulation of somatostatin secretion in the isolated perfused human pancreas.

Authors:  F C Brunicardi; D Elahi; D K Andersen
Journal:  Ann Surg       Date:  1994-03       Impact factor: 12.969

7.  Difference in calcium dependency of insulin, glucagon and somatostatin secretion in response to glibenclamide in perfused rat pancreas.

Authors:  S Efendić; V Grill; A Nylén; C G Ostensson
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

8.  Characterisation of the abnormal pancreatic D and A cell function in streptozotocin diabetic dogs: studies with D-glyceraldehyde, dihydroxyacetone, D-mannoheptulose, D-glucose, and L-arginine.

Authors:  K Hermansen
Journal:  Diabetologia       Date:  1981-11       Impact factor: 10.122

9.  Release of somatostatin-like immunoreactivity from the perfused canine thyroid. Selective stimulatory effect of calcium ions.

Authors:  P Laurberg; H Orskov
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

10.  Sustained oscillations of insulin, glucagon, and somatostatin from the isolated canine pancreas during exposure to a constant glucose concentration.

Authors:  J I Stagner; E Samols; G C Weir
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.